Movie Industry

'Chiikawa' Tops Weekend Box Office… 150,000 Viewers

Cumulative total: 2.79 million No. 2: “Final Interview” · No. 3: “Heart of the Beast”

Choi Hee-jae
2026-11-09 08:22:07
[Edaily Reporter Choi Hee-jae ] The Japanese animated film "Chiikawa: The Secret of the Mermaid Island" (Chiikawa) remained at the top of the box office over the weekend.
Still from the movie “Chiikawa: The Secret of Mermaid Island” (Photo courtesy of CJ ENM)

According to the Korean Film Council’s integrated computer network on the 9th, “Chiikawa” drew 149,051 viewers over the three days from the 6th to the 8th, taking the No. 1 spot at the weekend box office. Its cumulative audience count stands at 2,788,844.

“Chiikawa” is an animated film depicting a mysterious expedition in which Chiikawa and her friends, lured by the sweet temptation of 100 times their usual pay, set off for an unknown island to uncover the secrets hidden there.

The Korean film “Final Interview,” which opened on the 4th, took second place by drawing 104,482 viewers during the same period. Its cumulative attendance stands at 166,802. Third place went to “Heart of the Beast,” which drew 90,679 viewers, bringing its cumulative attendance to 379,763.

“Detective Conan: The 30th Murder Case,” which opened on the 5th, ranked fourth with 79,999 weekend viewers. Its cumulative attendance stands at 108,164. The animated film “The Cat in the Hat,” which opened on the 6th, drew 29,259 viewers, debuting in fifth place. Its cumulative attendance stands at 31,449.

“Chiikawa” continues its long-running success, maintaining the No. 1 spot at the weekend box office even in its sixth week of release. With three animated films—“Detective Conan: The Murder in Apartment 30,” “The Cat in the Hat,” and “Chiikawa”—all ranking in the top five at the weekend box office, all eyes are on whether this upward trend will continue.

Economy

Corporation

IT·Science

Economy

Xcell Therapeutics Inc. Aims to Raise 8 Billion Won by Year-End… Will It Avoid the Risk of Negative Equity?

#Xcell Therapeutics Inc. is pursuing a third-party private placement worth 7 to 8 billion won to avoid the risk of negative equity by year-end. This comes after the company raised funds through a 9.5 …
2026-11-09 08:02:02

Corporation

GemVax & KAEL Co.,Ltd. Announces Results of 72-Week Clinical Trial for ‘GV1001’ in London… Prepares for Global Phase 3 Clinical Trial Following PSP Trial

GemVax & KAEL Co.,Ltd. announced the results of a 72-week clinical trial for “GV1001,” a candidate drug for progressive supranuclear palsy (PSP), in London, UK. At the event, the company engaged with …
2026-11-09 08:35:02

IT·Science

Samsung Bioepis Confirms Equivalence in Phase 3 Clinical Trial of Keytruda Biosimilar

A Samsung Bioepis representative (left) explains the results of the global Phase 3 clinical trial for the Keytruda biosimilar “SB27” at the Society for Immunotherapy of Cancer (SITC) 2026 conference h…
2026-11-09 08:33:02